Neck Lymphatic Microsurgery for People With Mild Alzheimer's Disease
Tests neck lymphatic microsurgery in adults with mild Alzheimer's disease.
Plain-language title generated from the registry record
Registry title: Cervical Lymphatic Microsurgery in Alzheimer's Disease
Key facts
- Where
- Gdansk and Słupsk, PolandSee the 2 sites
Where in Poland
- Uniwersyteckie Centrum Kliniczne w GdańskuGdansk, PolandTaking people
- Wojewódzki Szpital Specjalistyczny im. Janusza Korczaka w Słupsku Sp. z o.o.Słupsk, PolandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Daniel Maliszewski
- Trial code
- NCT07857759
- Record updated
- 8 October 2026
- Original description
This pilot study will evaluate whether microsurgical modification of cervical lymphatic drainage may influence blood biomarkers and clinical outcomes in people with mild Alzheimer's disease.Read full original descriptionShow less
Microsurgical Modification of Cervical Lymphatic Pathways in Alzheimer's Disease: A Pilot Study
This pilot study will evaluate whether microsurgical modification of cervical lymphatic drainage may influence blood biomarkers and clinical outcomes in people with mild Alzheimer's disease.
Thirty participants will be randomly assigned in a 1:1 ratio to either a surgical intervention group or a control group. Participants in the intervention group will undergo supermicrosurgical lymphaticovenous anastomosis (LVA) and/or lymph node-to-vein anastomosis (LNVA) in the neck to create an alternative pathway for lymphatic drainage. The procedure may be performed manually or with robotic microsurgical assistance. Participants in the control group will receive clinical observation without surgery during the first 12 months.
The primary objective is to assess the change in plasma phosphorylated tau 217 (p-tau217) from baseline to 12 months. The study will also assess changes in cognitive and functional measures, including the Clinical Dementia Rating Sum of Boxes (CDR-SB), Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL), Montreal Cognitive Assessment (MoCA), and Mini-Mental State Examination (MMSE), as well as the feasibility and safety of the surgical procedure.
Participants will be assessed at baseline and at 3, 6, and 12 months. After completion of the 12-month observation period, participants in the control group may be offered the surgical procedure if they wish to undergo it.
Inclusion: Age 18 years or older; Clinical diagnosis of mild Alzheimer's disease according to National Institute on Aging-Alzheimer's Association (NIA-AA) criteria; Clinical Dementia Rating (CDR) score of 0.5 to 1.0; Mini-Mental State Examination (MMSE) score of 20 to 26; Confirmation of Alzheimer's disease pathology using plasma biomarkers, with elevated phosphorylated tau 217 (p-tau217); Stable pharmacological treatment for Alzheimer's disease for at least 3 months before enrollment; Ability to provide informed consent or consent provided by a legally authorized representative.
Exclusion: Previous major neck surgery or radiotherapy to the neck that may affect lymphatic drainage; Moderate or severe Alzheimer's disease; Other neurodegenerative disorders or significant psychiatric disorders; Active infection or coagulation disorders; Contraindications to general anesthesia.